Strategic Partnerships Perimed AB has recently expanded its distribution reach through a major UK collaboration with Healthcare 21 Group, signaling open sales channels in Europe and potential co-selling with a large medtech distributor to access a broad clinician network.

Manufacturing Continuity Radiometer Medical assets were acquired by Perimed AB to continue manufacturing E5250 TcpO2 electrode and D826 membraning kit, ensuring product continuity and compatibility for existing customers potentially seeking reliable supply and upgrade paths.

Acquisition Backing A strategic investment stake from Serendipity Partners (49% ownership) indicates strong backing for growth initiatives, enabling accelerated product development, market expansion, and larger-scale sales efforts.

Global Reach With subsidiaries in the US, China, France, Italy, and Germany, and a Swedish HQ coordinating distributors, there are established routes to enter or scale in multiple markets, offering cross-border upsell of diagnostic solutions for microcirculation and peripheral perfusion.

Revenue Fit Operating in the medical diagnostics equipment space with revenue in the one to multi-million range, Perimed targets specialized clinical and research markets, making it suitable for value-based selling of noninvasive peripheral vascular assessment tools to hospitals, clinics, and labs seeking advanced microcirculation solutions.